Minireviews Open Access
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Stomatol. May 20, 2014; 3(2): 19-24
Published online May 20, 2014. doi: 10.5321/wjs.v3.i2.19
Host-derived biomarkers in gingival crevicular fluid for complementary diagnosis of apical periodontitis
Mauricio Garrido, Andrea Dezerega, Alfredo Castro-Martínez, Marcela Hernández
Mauricio Garrido, Andrea Dezerega, Alfredo Castro-Martínez, Marcela Hernández, Laboratorio de Biología Periodontal, Facultad de Odontología, Universidad de Chile, Santiago 8380492, Chile
Mauricio Garrido, Andrea Dezerega, Departamento de Odontología Conservadora, Facultad de Odontología, Universidad de Chile, Santiago 8380492, Chile
Marcela Hernández, Departamento de Patología y Medicina Oral, Facultad de Odontología, Universidad de Chile, Santiago 8380492, Chile
Author contributions: All authors contributed equally to this work.
Supported by Project grants from Scientific and Technologic Investigation Resource (FONDECYT), Santiago, Chile, No. N° 1090461 and 1120138
Correspondence to: Dr. Marcela Hernández, Departamento de Patología y Medicina Oral, Facultad de Odontología, Universidad de Chile, Avenida Sergio Livingstone 943, Comuna de Independencia, Santiago 8380492, Chile. mhernandezrios@gmail.com
Telephone: +56-2-8781810 Fax: +56-2-7779724
Received: March 5, 2014
Revised: May 7, 2014
Accepted: May 14, 2014
Published online: May 20, 2014

Abstract

Apical periodontitis (AP) develops as a result of the host’s immune inflammatory response to pulpal infection of the dental root canals that leads to the generation of an apical lesion of endodontic origin (ALEO) and potentially to systemic metabolic alterations. Misdiagnosed ALEO is not infrequent due to the lack of diagnostic tools to differentiate apical lesions of different natures. Despite the conservative endodontic treatment shows a high success rate, there are refractory cases that can not be identified early enough during follow up. This evidences the need to develop complementary diagnostic tools, such as oral fluid biomarker analysis. Gingival crevicular fluid (GCF) is a serum transudate that becomes an exudate under inflammatory conditions, carrying molecules from local periodontal tissues and general circulation than can be harvested non-invasively. We aimed to review the available literature analyzing GCF composition in AP patients to evaluate whether GCF has any potential for complementary diagnosis. To the date, only few studies addressing changes of GCF components in AP are available. Most studies support GCF modifications in specific components in AP-affected teeth, suggesting that it might reflect periapical inflammation. GCF has potential for diagnostic tool, treatment follow-up and eventually to assess systemic comprise.

Key Words: Gingival crevicular fluid, Periapical periodontitis, Biomarkers, Diagnosis, Prognosis

Core tip: The hallmark of Apical periodontitis (AP) is the development of an apical lesion of endodontic origin and can potentially lead to systemic alterations. Avoiding misdiagnosis and follow up are among the main challenges in its clinical management. The current review addresses the studies evaluating gingival crevicular fluid (GCF) composition in AP patients reported in the literature. Specific components vary in AP-affected teeth, supporting that GCF has potential for complementary diagnosis and treatment follow-up.



INTRODUCTION

Apical periodontitis (AP) usually results as consequence of pulpal infection caused by bacteria inside the root canal system of the teeth, where they organize in biofilms. Endodontic bacterial biofilms are conspicuously dominated by Gram-negative anaerobic bacteria[1,2]. The endodontic offenders and their major byproducts, endotoxins, elicit a sustained immune-inflammatory response that attempts to localize the infection and prevent further dissemination at the expense of apical periodontal tissue breakdown, involving periodontal ligament, radicular cementum and alveolar bone[3]. Additionally, increasing evidence links AP with systemic inflammation, elevated risk of cardiovascular diseases (CVD), specially atherogenesis[4], and diabetic metabolic dyscontrol[5].

During the chronic phase of AP, a bone resorptive lesion results evident as an apical radiolucent area in a radiograph. Histologically, apical lesions of endodontic origin (ALEO) consist of granulation tissue (apical granuloma) and can progress to form a radicular cyst, whenever chronic inflammatory process stimulates epithelial rests of Malassez. A radicular cyst is composed of a pathological cavity lined by squamous epithelium and a connective tissue capsule with varying degrees of inflammation. Both, apical granuloma and radicular cyst seem to represent different stages from the same process[3].

Apical lesions usually present clinically as a chronic infection, remaining as asymptomatic AP (AAP). Because the balance among inflammation and bacteria is a dynamic process, AAP may undergo an acute exacerbation and become symptomatic, presenting as symptomatic apical periodontits or acute abscess, or it may evolve from the acute to the chronic stage[6].

Frequently, AP can be managed with conservative endodontic treatment consisting of instrumentation, disinfection and obturation of the root canal from the affected tooth, followed by restoration of the tooth crown[7]. The major aim of the conservative therapy is to significantly reduce bacterial load and to induce consecutive healing of apical tissues. Nevertheless, some epidemiologic studies reveal a prevalence of apical lesions in endodontically-treated teeth as high as 65%[8]. Rehabilitation of these teeth on the other hand, requires long and expensive therapies that involve canal treatment and restoration of the lost crown. Thus, the need for developing complimentary tools for diagnosis and follow up becomes evident. Gingival crevicular fluid (GCF) carries molecules from local periodontal tissues and general circulation and can be harvested non-invasively from the gingival crevice and thus, its composition might reflect AP[9]. Our aim is to review the available literature addressing GCF composition in AP patients in order to identify whether it might have potential as a complimentary diagnostic tool for clinical endodontic practice.

OVERVIEW OF AP PATHOGENESIS

The initiation of the inflammatory response during AP includes the complex interplay of multiple cell types, involving resident and infiltrating cells[10]. Periradicular infiltrates are mainly composed of macrophages, T and B lymphocytes, plasma-cells and polimorphonuclear neutrophils (PMNs)[11-13]. Although macrophages are recognized as one of the major cell types[3], the relative composition of these cellular infiltrates remains controversial and recent data of our work group has revealed a high proportion of mast cells among the inflammatory infiltrates, positioning these cells as the more frequent subpopulation after lymphocytes[14].

Elicitation of the immune inflammatory response against bacteria from the infected root canal is known to play a pivotal role in AP, involving phagocytosis, activation of humoral and cellular responses and production of inflammatory mediators, including cytokines, such as interleukin (IL)-1β and tumor necrosis factor (TNF)-α[15], reactive oxygen species (ROS) and matrix metalloproteinases (MMPs)[16], among others. As consequence, the breakdown of the extracellular matrix from the periodontal tissues leads to the development and progression of an ALEO[17]. The host might respond to bacteria and cytokine dumping from apical lesions through systemic inflammation, as for other chronic inflammatory processes, such as chronic periodontitis. Systemic inflammation in turn, has been increasingly associated with elevated risk of systemic conditions, such as CVD[4].

GCF

Endodontic diagnosis and treatment is challenging from a clinical point of view. Difficulties include differential diagnosis of apical lesions, such as apical granuloma, radicular cyst (true and pocket cysts), apical scars and other non inflammatory lesions, whereas conservative treatment outcome is difficult to predict in the short term based upon clinical and radiographic criteria, requiring long follow up periods[18,19]. Thus, the need for the developing of new methods for diagnosis and follow up, such as the analysis of oral fluid biomarkers, becomes evident and might contribute to optimize the associated human and economic costs. Additionally, it might result in improvements of the treatment modalities and prevention of possible systemic consequences derived from chronic apical foci.

Classic studies addressing the pathogenesis of AP have been performed within the frame of the available sampling methods, including apical exudates via root canals[20] and the analysis of ALEO. Nevertheless, they are limited by the lack of proper healthy controls and/or the impediment to carry out longitudinal treatment follow-up, respectively. GCF sampling on the other hand is harvested non-invasively, is site-specific and thus, permits longitudinal follow up and adequate healthy controls for the affected teeth[17].

Under physiologic conditions GCF is proposed to represent a transudate from serum, whereas under inflammatory conditions it becomes an exudate that carries molecules from both, interstitial periodontal tissues and general circulation[21], that might reflect local periodontal and systemic inflammation[22]. GCF analysis has widely been used in periodontics and can provide adjunctive information for health care professionals along side with traditional oral clinical examination, including disease presence, severity, healing phase and treatment outcome[23-28]. Furthermore, it has been suggested that the analysis of local changes in oral fluids have a potential to build up a diagnostic bridge from mouth to systemic conditions[29]. In this context, the remaining question would be whether GCF might also reflect the local and systemic changes associated with AP.

ANALYSIS OF GCF COMPOSITION IN AP

The studies addressing the changes in GCF composition are shown in Table 1. The first report using GCF analysis in AP was an analytic study from Belmar et al[17], evaluating the activity of MMP-2 and -9 in teeth with AL and healthy contralateral controls in AAP individuals. MMPs enclose a family of genetically distinct, but structurally related zinc-dependent proteolytic enzymes that can synergistically degrade almost all extracellular matrix and basement membrane components, and regulate several cellular processes, including inflammation. MMPs are classified based on their primary structures and substrate specificities into different groups, where collagenases (MMP-1, -8 and -13) and gelatinases (MMP-9 and -2) are regarded to play a pivotal role in the breakdown of the periodontal tissues[30]. The authors found higher activity levels in AAP for both enzymes, as well as unidentified gelatinolytic bands of 48-56 kDa, suggestive of MMP-13. Although statistically significant differences were found only for the MMP-9 proform, active MMP-2 was exclusively identified in GCF from AAP teeth. In line with these results, MMP-2 and MMP-9 have been identified in experimentally-induced AP in animal models, human apical granulomas and radicular cysts, as well as exudates from apical abscesses[31-33]. Gelatinolytic MMP activity in ALEO in humans was confirmed in a recent study reporting higher activity of MMP-2 and MMP-9 in comparison to healthy periodontal ligament controls[16].

Table 1 Summary of the studies analyzing gingival crevicular fluid composition in apical periodontitis.
Ref.Study groupsParametersnResults (P < 0.05)
Dezerega et al[16]AAP and healthy controlsOxidative balanceAAP, n = 10 controls, n = 13Statistically non significant.
AAP pre and post endodontic interventionOxidative balancen = 16Increase in total antioxidant status after the intervention
Garrido Flores et al[47]AAP and healthy controlsTotal protein concentration and TNF-α levelsn = 14Higher TNF-α levels in AAP
Shin et al[11]AP and healthy controlsMMP-8 and substance P levelsn = 35Higher levels of MMP-8 and substance P in AP. P value not reported
AP pre and post endodontic interventionMMP-8 y substance P levelsn = 35Decrease in MMP-8 and substance P after the intervention
Burgener et al[46]AP and healthy controlsTotal protein concentration and IL-1β y DSP levelsn = 40Higher total protein concentration in AP
Belmar et al[17]AAP and healthy controlsMMP-9 and MMP-2 activityn = 20Higher pro-MMP-9 activity in AAP. Active MMP-2 bands detected only in AAP

Additionally, MMP-8 has also been immunolocalized to human periapical granuloma and inflamed pulp, and its levels decreased with statistical significance after intracanal calcium hydroxide medication[34]. MMP-13 on the other hand was suggested to associate with the proliferation of epithelial tissue and the development of a radicular cyst from a preexisting granuloma[3,34,35]. In line with these findings, a study performed in experimentally-induced apical lesions proposed that MMP-13 along with MMP-8 act sequentially in the development and progression of ALEO, respectively[36].

Numerous works support that MMP-2, -9, -8 and -13 play an important role in both, the initiation and progress of inflammatory bone resorption and soft tissue breakdown during pathological processes, including periodontitis. Among them, MMP-8 and MMP-9 are by far the predominant MMPs in GCF, and their major source are regarded to be PMNs, monocytes and macrophages[16,22,24,37-41]. MMP-8 and MMP-9 are substantially involved in the progression of chronic periodontitis[37,39,42] and might represent the most promising biomarkers for periodontal inflammation and disease severity[43]. Additionally, increments of MMPs-8 and -9 associated with an altered lipid profile and have been proposed to represent early markers of atherosclerosis in individuals with marginal periodontal diseases[44,45].

Another study from Burgener et al[46] analyzed the total protein concentration, and the levels of IL-1β and dentin sialoprotein (DSP) in subjects with AP and healthy contralateral control teeth and found significantly elevated total protein concentration in the former. The studies of Belmar et al[17] and Burgener et al[46] applied a similar methodology, in which they included a healthy contralateral control tooth and excluded the presence of marginal periodontal diseases. Nevertheless, the studies differed in the normalization methods for result expression. While the former expressed absolute values in a standard time of 30 s GCF collection, the later normalized IL-1β and DSP levels by the total protein content. In this regard, a wide range of studies performed in chronic periodontitis demonstrate that total protein content in GCF represents a variable itself, increasing along with periodontal inflammation. This might be explained primarily by albumin extravasation from serum. Consequently, the best proposed method of standardization for the specific protein determinations in GCF is through a fixed time of sample collection[22,42]. This difference might explain the lack of differences found for IL-1β and DSP.

In addition, TNF-α was reported to be higher in GCF from AAP when compared to healthy contralateral teeth[47]. In contrast to the previous study, the authors did not find statistically significant differences in total protein concentration between both groups. In line with the reported changes in GCF, TNF-α was higher in ALEO in comparison with healthy periradicular tissues[48]. IL-1 and TNF-α, on the other hand, were identified in apical exudates of teeth with ALEO and particularly, IL-1 levels were statistically higher in larger lesions and tended to associate with the presence of clinical symptoms, but it was not statistically significant[15].

Recently, an oxidant imbalance in favor to a pro-oxidant status was reported by our group in GCF from AAP vs healthy contralateral teeth. A week after the completion of the endodontic treatment, the oxidative status reached similar levels to those observed for healthy controls. The authors also measured the oxidant status and the activity of MMP-2 and MMP-9 in ALEO and a pro-oxidant status was also found when compared with healthy periodontal ligaments, in direct correlation with the size of the apical lesion[16]. Large evidence links ROS with tissue damage in inflammatory diseases. ROS can activate proinflammatory signaling pathways and induce bone resorption[49,50]. In support of these results, ROS production by blood PMNs was higher in individuals with ALEO compared to healthy controls, and their levels decreased after the extraction of the affected teeth[13]. These data suggest that an oxidative imbalance might play a central role in local and systemic mechanisms involved in the pathogenesis of ALEO and that these changes might be reflected in GCF from the affected teeth.

In summary, GCF represents a simple, non invasive and useful tool in monitoring periodontal inflammation and treatment response. Up to now, only few studies have analyzed the changes in GCF components that might be involved in the pathogenesis of AP individuals. Despite this fact, all of them report identifiable differences in at least one of its specific components, either when compared to healthy controls or in prospective follow up approaches. These studies suggest that GCF might reflect periapical inflammation, although the results among the different studies are not completely consistent. Future studies are needed to further clarify whether GCF reflects local or systemic inflammation in AAP in order to establish a new diagnostic tool for traditional clinical endodontics to aid in complimentary diagnosis, treatment follow-up and to assess potential systemic comprise.

CONCLUSION

GCF composition can be modified in the presence of AP, supporting its usefulness for potential diagnostic tool, treatment follow-up and eventually to assess systemic comprise.

Footnotes

P- Reviewers: Abundo R, Ferreira MM, Mahajan A, Spagnuolo G S- Editor: Song XX L- Editor: A E- Editor: Liu SQ

References
1.  Rôças IN, Siqueira JF. Root canal microbiota of teeth with chronic apical periodontitis. J Clin Microbiol. 2008;46:3599-3606.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 110]  [Cited by in F6Publishing: 116]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
2.  Ozbek SM, Ozbek A. Real-time polymerase chain reaction of “red complex” (Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola) in periradicular abscesses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:670-674.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 13]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
3.  Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med. 2004;15:348-381.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 559]  [Cited by in F6Publishing: 589]  [Article Influence: 29.4]  [Reference Citation Analysis (0)]
4.  Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35:277-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 443]  [Cited by in F6Publishing: 477]  [Article Influence: 29.5]  [Reference Citation Analysis (0)]
5.  Segura-Egea JJ, Castellanos-Cosano L, Machuca G, López-López J, Martín-González J, Velasco-Ortega E, Sánchez-Domínguez B, López-Frías FJ. Diabetes mellitus, periapical inflammation and endodontic treatment outcome. Med Oral Patol Oral Cir Bucal. 2012;17:e356-e361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 82]  [Article Influence: 6.5]  [Reference Citation Analysis (0)]
6.  Gutmann JL, Baumgartner JC, Gluskin AH, Hartwell GR, Walton RE. Identify and define all diagnostic terms for periapical/periradicular health and disease states. J Endod. 2009;35:1658-1674.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 60]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
7.  Cotti E, Dessì C, Piras A, Mercuro G. Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the literature. Int J Cardiol. 2011;148:4-10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 69]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
8.  Kim S. Prevalence of apical periodontitis of root canal-treated teeth and retrospective evaluation of symptom-related prognostic factors in an urban South Korean population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:795-799.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
9.  Hernández P, Mäntylä P, Tervahartiala T, Sorsa T, Hernández M. Oral-fluid MMP analysis in the complementary diagnosis of periodontal diseases. Oral Vol. 2012;5:150-153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
10.  Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol. 2011;3.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 177]  [Cited by in F6Publishing: 202]  [Article Influence: 14.8]  [Reference Citation Analysis (0)]
11.  Shin SJ, Lee JI, Baek SH, Lim SS. Tissue levels of matrix metalloproteinases in pulps and periapical lesions. J Endod. 2002;28:313-315.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 105]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
12.  Vernal R, Dezerega A, Dutzan N, Chaparro A, León R, Chandía S, Silva A, Gamonal J. RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis. 2006;12:283-289.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 62]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
13.  Minczykowski A, Woszczyk M, Szczepanik A, Lewandowski L, Wysocki H. Hydrogen peroxide and superoxide anion production by polymorphonuclear neutrophils in patients with chronic periapical granuloma, before and after surgical treatment. Clin Oral Investig. 2001;5:6-10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 21]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
14.  Cavalla F, Reyes M, Vernal R, Alvarez C, Paredes R, García-Sesnich J, Infante M, Fariña V, Barrón I, Hernández M. High levels of CXC ligand 12/stromal cell-derived factor 1 in apical lesions of endodontic origin associated with mast cell infiltration. J Endod. 2013;39:1234-1239.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
15.  Ataoğlu T, Ungör M, Serpek B, Haliloğlu S, Ataoğlu H, Ari H. Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates. Int Endod J. 2002;35:181-185.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 62]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
16.  Dezerega A, Madrid S, Mundi V, Valenzuela MA, Garrido M, Paredes R, García-Sesnich J, Ortega AV, Gamonal J, Hernández M. Pro-oxidant status and matrix metalloproteinases in apical lesions and gingival crevicular fluid as potential biomarkers for asymptomatic apical periodontitis and endodontic treatment response. J Inflamm (Lond). 2012;9:8.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 28]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
17.  Belmar MJ, Pabst C, Martínez B, Hernández M. Gelatinolytic activity in gingival crevicular fluid from teeth with periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:801-806.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 30]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
18.  Chazel JC, Tramini P, Valcarcel J, Pélissier B. A comparative analysis of periapical health based on historic and current data. Int Endod J. 2005;38:277-284.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
19.  Cunha EM, Fernandes AV, Versiani MA, Loyola AM. Unicystic ameloblastoma: a possible pitfall in periapical diagnosis. Int Endod J. 2005;38:334-340.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 23]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
20.  Shimauchi H, Miki Y, Takayama S, Imai T, Okada H. Development of a quantitative sampling method for periapical exudates from human root canals. J Endod. 1996;22:612-615.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 20]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
21.  Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000. 2003;31:32-42.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 208]  [Cited by in F6Publishing: 225]  [Article Influence: 10.4]  [Reference Citation Analysis (0)]
22.  Hernández M, Martínez B, Tejerina JM, Valenzuela MA, Gamonal J. MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. J Clin Periodontol. 2007;34:729-735.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 50]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
23.  Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci. 1999;878:130-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 103]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
24.  Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38:306-321.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 450]  [Cited by in F6Publishing: 415]  [Article Influence: 28.1]  [Reference Citation Analysis (0)]
25.  Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004;10:311-318.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 394]  [Cited by in F6Publishing: 408]  [Article Influence: 21.9]  [Reference Citation Analysis (0)]
26.  Mäntylä P, Stenman M, Kinane D, Salo T, Suomalainen K, Tikanoja S, Sorsa T. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res. 2006;41:503-512.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 98]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
27.  Mäntylä P, Stenman M, Kinane DF, Tikanoja S, Luoto H, Salo T, Sorsa T. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res. 2003;38:436-439.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 149]  [Cited by in F6Publishing: 153]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
28.  Munjal SK, Prescher N, Struck F, Sorsa T, Maier K, Netuschil L. Evaluation of immunoassay-based MMP-8 detection in gingival crevicular fluid on a point-of-care platform. Ann N Y Acad Sci. 2007;1098:490-492.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 17]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
29.  Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, Lauhio A, Pussinen PJ, Mäntylä P. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res. 2011;63:108-113.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 93]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
30.  Folgueras AR, Pendás AM, Sánchez LM, López-Otín C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004;48:411-424.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 397]  [Cited by in F6Publishing: 350]  [Article Influence: 22.1]  [Reference Citation Analysis (0)]
31.  Carneiro E, Menezes R, Garlet GP, Garcia RB, Bramante CM, Figueira R, Sogayar M, Granjeiro JM. Expression analysis of matrix metalloproteinase-9 in epithelialized and nonepithelialized apical periodontitis lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:127-132.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 33]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
32.  de Paula-Silva FW, D’Silva NJ, da Silva LA, Kapila YL. High matrix metalloproteinase activity is a hallmark of periapical granulomas. J Endod. 2009;35:1234-1242.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 40]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
33.  Buzoglu HD, Unal H, Ulger C, Mert S, Kücükyildirim S, Er N. The zymographic evaluation of gelatinase (MMP-2 and -9) levels in acute and chronic periapical abscesses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e121-e126.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
34.  Wahlgren J, Salo T, Teronen O, Luoto H, Sorsa T, Tjäderhane L. Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates. Int Endod J. 2002;35:897-904.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 78]  [Cited by in F6Publishing: 84]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
35.  Leonardi R, Caltabiano R, Loreto C. Collagenase-3 (MMP-13) is expressed in periapical lesions: an immunohistochemical study. Int Endod J. 2005;38:297-301.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 43]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
36.  Matsui H, Yamasaki M, Nakata K, Amano K, Nakamura H. Expression of MMP-8 and MMP-13 in the development of periradicular lesions. Int Endod J. 2011;44:739-745.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 25]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
37.  Hernández M, Gamonal J, Tervahartiala T, Mäntylä P, Rivera O, Dezerega A, Dutzan N, Sorsa T. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol. 2010;81:1644-1652.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 72]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
38.  Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez J, Lopez JM, Vernal R, Gamonal J. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol. 2006;77:1863-1870.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 78]  [Cited by in F6Publishing: 83]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
39.  Hernández Ríos M, Sorsa T, Obregón F, Tervahartiala T, Valenzuela MA, Pozo P, Dutzan N, Lesaffre E, Molas M, Gamonal J. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J Clin Periodontol. 2009;36:1011-1017.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 67]  [Cited by in F6Publishing: 71]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
40.  Nishikawa M, Yamaguchi Y, Yoshitake K, Saeki Y. Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts. J Periodontal Res. 2002;37:167-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 61]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
41.  Hernández M, Dutzan N, García-Sesnich J, Abusleme L, Dezerega A, Silva N, González FE, Vernal R, Sorsa T, Gamonal J. Host-pathogen interactions in progressive chronic periodontitis. J Dent Res. 2011;90:1164-1170.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 124]  [Cited by in F6Publishing: 128]  [Article Influence: 10.3]  [Reference Citation Analysis (0)]
42.  Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, Giannobile WV. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310-319.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 198]  [Cited by in F6Publishing: 204]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
43.  Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. 2010;16:39-45.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 109]  [Cited by in F6Publishing: 114]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
44.  Söder B, Airila Månsson S, Söder PO, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res. 2006;41:411-417.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 60]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
45.  Söder PO, Meurman JH, Jogestrand T, Nowak J, Söder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res. 2009;44:452-458.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 38]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
46.  Burgener B, Ford AR, Situ H, Fayad MI, Hao JJ, Wenckus CS, Johnson BR, BeGole EA, George A. Biologic markers for odontogenic periradicular periodontitis. J Endod. 2010;36:1307-1310.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
47.  Garrido Flores M, Segú Cabrera C, Baeza Paredes M, García-Sesnich J, Hernández Ríos M. Asociación entre niveles de TNF-a en fluido crevicular gingival de dientes con periodontitis apical asintomática. Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral. 2011;4:130-133.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
48.  Prso IB, Kocjan W, Simic H, Brumini G, Pezelj-Ribaric S, Borcic J, Ferreri S, Karlovic IM. Tumor necrosis factor-alpha and interleukin 6 in human periapical lesions. Mediators Inflamm. 2007;2007:38210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 18]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
49.  Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med. 2001;31:509-519.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 587]  [Cited by in F6Publishing: 604]  [Article Influence: 26.7]  [Reference Citation Analysis (0)]
50.  D’Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 2010;89:1241-1246.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 207]  [Cited by in F6Publishing: 226]  [Article Influence: 15.9]  [Reference Citation Analysis (0)]